Medigy Logo News
Person name
Published by
@ShahidNShah
GE HealthCare Receives FDA Clearance for Alzheimer's Imaging Tool

GE HealthCare Receives FDA Clearance for Alzheimer's Imaging Tool

GE HealthCare's MIM Software received FDA clearance for Centiloid scaling in PET imaging for Alzheimer's disease.

– GE HealthCare announced today that its MIM Software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a groundbreaking tool in the fight against Alzheimer’s disease. 

– The advancement allows MIMneuro, a vendor-neutral software solution, to perform “Centiloid scaling” for analyzing and quantifying amyloid plaque density in the brain using positron emission tomography (PET) imaging.

Read on hitconsultant.net

Make faster decisions with community advice

Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2024 Netspective Foundation, Inc. All Rights Reserved.

Built on Dec 17, 2024 at 12:55pm

This website uses cookies

These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience, and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookie Policy.

Please consent to the use of cookies before continuing to browse our site.